103 related articles for article (PubMed ID: 15695299)
1. Advanced refractory polymyositis responding to infliximab.
Anandacoomarasamy A; Howe G; Manolios N
Rheumatology (Oxford); 2005 Apr; 44(4):562-3. PubMed ID: 15695299
[No Abstract] [Full Text] [Related]
2. Refractory polymyositis responding to infliximab.
Uthman I; El-Sayad J
Rheumatology (Oxford); 2004 Sep; 43(9):1198-9. PubMed ID: 15317962
[No Abstract] [Full Text] [Related]
3. Refractory polymyositis responding to infliximab: extended follow-up.
Labioche I; Liozon E; Weschler B; Loustaud-Ratti V; Soria P; Vidal E
Rheumatology (Oxford); 2004 Apr; 43(4):531-2. PubMed ID: 15024143
[No Abstract] [Full Text] [Related]
4. Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab.
Marie I; Heliot P; Roussel F; Hervé F; Muir JF; Levesque H
Rheumatology (Oxford); 2005 Sep; 44(9):1201-2. PubMed ID: 15941728
[No Abstract] [Full Text] [Related]
5. Refractory vertebral sarcoidosis responding to infliximab.
Garg S; Garg K; Altaf M; Magaldi JA
J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
[TBL] [Abstract][Full Text] [Related]
6. Infliximab efficiency in refractory Wegener's granulomatosis.
Rozin A
Rheumatology (Oxford); 2003 Sep; 42(9):1124-5; author reply 1125-6. PubMed ID: 12923277
[No Abstract] [Full Text] [Related]
7. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.
Ideguchi H; Ohno S; Takase K; Hattori H; Kirino Y; Takeno M; Ishigatsubo Y
Rheumatology (Oxford); 2007 Oct; 46(10):1621-2. PubMed ID: 17726035
[No Abstract] [Full Text] [Related]
8. Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up.
Hengstman GJ; van den Hoogen FH; van Engelen BG
Eur Neurol; 2004; 52(1):61-3. PubMed ID: 15240986
[No Abstract] [Full Text] [Related]
9. [Anti TNF-alpha treatment of a refractory polymyositis].
Wendling D; Prati C; Ornetti P; Toussirot E; Streit G
Rev Med Interne; 2007 Mar; 28(3):194-5. PubMed ID: 17240483
[TBL] [Abstract][Full Text] [Related]
10. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.
Cazabon S; Over K; Butcher J
Eye (Lond); 2005 Feb; 19(2):222-4. PubMed ID: 15258602
[No Abstract] [Full Text] [Related]
11. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab.
Mpofu S; Estrach C; Curtis J; Moots RJ
Rheumatology (Oxford); 2003 Sep; 42(9):1117-8. PubMed ID: 12923271
[No Abstract] [Full Text] [Related]
12. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis.
Hammoudeh M
Rheumatology (Oxford); 2006 Mar; 45(3):357-9. PubMed ID: 16368727
[No Abstract] [Full Text] [Related]
13. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
14. Anti-tuberculosis treatment and infliximab.
Wallis RS
Respir Med; 2005 Dec; 99(12):1620-2. PubMed ID: 16039841
[No Abstract] [Full Text] [Related]
15. Alemtuzumab (Campath-1H) for treatment of refractory polymyositis.
Thompson B; Corris P; Miller JA; Cooper RG; Halsey JP; Isaacs JD
J Rheumatol; 2008 Oct; 35(10):2080-2. PubMed ID: 18843768
[No Abstract] [Full Text] [Related]
16. Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy.
Ashok D; Ayliffe WH; Kiely PD
Rheumatology (Oxford); 2005 Jul; 44(7):950-1. PubMed ID: 15827040
[No Abstract] [Full Text] [Related]
17. Infliximab infusions for persistent back pain in two patients with Schmorl's nodes.
Sakellariou GT; Chatzigiannis I; Tsitouridis I
Rheumatology (Oxford); 2005 Dec; 44(12):1588-90. PubMed ID: 16234274
[No Abstract] [Full Text] [Related]
18. Bacillus calmette-guérin vaccination in a patient treated with infliximab.
Toussirot E; Wendling D
J Rheumatol; 2005 Dec; 32(12):2500-1. PubMed ID: 16331800
[No Abstract] [Full Text] [Related]
19. Is TNFalpha really a good therapeutic target in motoneuronal degeneration? A case of amyotrophic lateral sclerosis in a patient with RA receiving infliximab.
Dziadzio M; Reddy V; Rahman S; Mummery C; Keat A
Rheumatology (Oxford); 2006 Nov; 45(11):1445-6. PubMed ID: 16877458
[No Abstract] [Full Text] [Related]
20. Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.
Nikas SN; Voulgari PV; Takalou IP; Katsimbri P; Drosos AA
Ann Rheum Dis; 2005 Nov; 64(11):1665-7. PubMed ID: 16227426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
